Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial
2017 ◽
Vol 19
(10)
◽
pp. 1490-1494
◽
2014 ◽
Vol 8
(4)
◽
pp. 1191-1196
◽
2019 ◽
2019 ◽
2019 ◽
2003 ◽
Vol 19
(2)
◽
pp. 124-130
◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽